Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observer-Blinded Phase 3 Study to Evaluate the Safety and Immunogenicity of a Single Booster of the NVX-CoV2373 Vaccine in Adults Previously Vaccinated With the BBIBP-CorV Vaccine

NCT05249816 is registered in ClinicalTrials.gov with Cogna Technology Solutions LLC as lead sponsor.

NCT NCT05249816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05249816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observer-Blinded Phase 3 Study to Evaluate the Safety and Immunogenicity of a Single Booster of the NVX-CoV2373 Vaccine in Adults Previously Vaccinated With the BBIBP-CorV Vaccine
Lead sponsor
Cogna Technology Solutions LLC
Phase
Phase 3
Overall status
Completed
Start date
March 18, 2022
Completion date
May 4, 2023
Enrollment
1,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe acute respiratory syndrome coronavirus 2 (sars-cov-2)